Through marker staining and flow cytometry analysis, clones from IPF (mild, moderate, severe) and control groups showed no detectable difference in immunoreactivity to BCs markers Krt5 and p63, and reached comparable purities of 98% or above based on ITGA6 expression (Fig. 2B). Here, KRT5 is linked to idiopathic pulmonary fibrosis.